You are viewing an older, archived article. There may be more up to date articles on this subject, try a new search


Essentials

  • Upfront: Results from the 2009 bpacnz survey
  • Practice snippets:Dextropropoxyphene-containing medicines to be withdrawn • Sibutramine (Reductil) withdrawn from European markets • Mirtazapine newly funded on special authority
  • QUIZ FEEDBACK: Chronic kidney disease and oral health
  • Correspondence: Use of hand rubs with norovirus
  • Issue 25 Contents
Contents
  • Home
  • Latest articles
  • Best Practice Journal
  • Best Tests
 Home  |  About us  |  Contact us  | |  Return to top 
© bpacnz 2026